{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:13:01Z","timestamp":1793923981224,"version":"4.8.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":349,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jhep.2012.01.031","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T18:34:00Z","timestamp":1334255640000},"page":"421-429","source":"Crossref","is-referenced-by-count":390,"title":["Primovist, Eovist: What to expect?"],"prefix":"10.1016","volume":"57","author":[{"given":"Bernard E.","family":"Van Beers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hero K.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2012.01.031_b0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1148\/radiology.203.2.9114076","article-title":"Contrast-enhanced MR imaging of the liver","volume":"203","author":"Van Beers","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2012.01.031_b0010","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00261-008-9480-9","article-title":"Biomarkers in abdominal imaging","volume":"34","author":"Van Beers","year":"2009","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.jhep.2012.01.031_b0015","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00330-004-2236-1","article-title":"Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications","volume":"14","author":"Reimer","year":"2004","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2214\/AJR.10.4392","article-title":"Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver","volume":"195","author":"Ringe","year":"2010","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jhep.2012.01.031_b0025","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/RLI.0b013e31821a218a","article-title":"Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment","volume":"46","author":"Gschwend","year":"2011","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiology.183.1.1549695","article-title":"Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system","volume":"183","author":"Schuhmann-Giampieri","year":"1992","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2012.01.031_b0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/01.rli.0000184756.66360.d3","article-title":"Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths","volume":"40","author":"Rohrer","year":"2005","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0040","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/jmri.21689","article-title":"Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA","volume":"29","author":"Tamada","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jhep.2012.01.031_b0045","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/RLI.0b013e3181a24512","article-title":"Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA","volume":"44","author":"Zech","year":"2009","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0050","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/jmri.22241","article-title":"Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA (Gd-EOB-DTPA)-enhanced hepatic MR imaging?","volume":"32","author":"Haradome","year":"2010","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jhep.2012.01.031_b0055","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/jmri.21913","article-title":"Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI)","volume":"30","author":"Motosugi","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jhep.2012.01.031_b0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/RLI.0b013e3181f9c487","article-title":"Double-dose gadoxetic acid-enhanced magnetic resonance imaging in patients with chronic liver disease","volume":"46","author":"Motosugi","year":"2011","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00330-007-0716-9","article-title":"Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions","volume":"18","author":"Hammerstingl","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10534-008-9135-x","article-title":"Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review","volume":"21","author":"Port","year":"2008","journal-title":"Biometals"},{"key":"10.1016\/j.jhep.2012.01.031_b0075","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/jmri.22021","article-title":"NSF prevention in clinical practice: summary of recommendations and guidelines in the United States, Canada, and Europe","volume":"30","author":"Leiner","year":"2009","journal-title":"J Magn Reson Imaging"},{"issue":"Suppl. 2","key":"10.1016\/j.jhep.2012.01.031_b0080","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1016\/S1076-6332(96)80544-7","article-title":"Mechanism of hepatic uptake of gadoxetate disodium","volume":"3","author":"Weinmann","year":"1996","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2012.01.031_b0090","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/dmd.110.032862","article-title":"Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters","volume":"38","author":"Leonhardt","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2012.01.031_b0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-3565(24)34879-7","article-title":"Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1","volume":"290","author":"van Montfoort","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2012.01.031_b0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/0264-6021:3450115","article-title":"Molecular cloning and functional characterization of the mouse organic-anion-transporting polypeptide 1 (Oatp1) and mapping of the gene to chromosome X","volume":"345","author":"Hagenbuch","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2012.01.031_b0430","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jhep.2012.01.031_b0110","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1111\/j.1742-4658.2011.08235.x","article-title":"Multidrug resistance proteins (MRPs\/ABCCs) in cancer chemotherapy and genetic diseases","volume":"278","author":"Chen","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.jhep.2012.01.031_b0115","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1515\/BC.2000.063","article-title":"Retrieval of the mrp2 gene encoded conjugate export pump from the canalicular membrane contributes to cholestasis induced by tert-butyl hydroperoxide and chloro-dinitrobenzene","volume":"381","author":"Schmitt","year":"2000","journal-title":"Biol Chem"},{"key":"10.1016\/j.jhep.2012.01.031_b0120","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2001.24034","article-title":"Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver","volume":"33","author":"Beuers","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.01.031_b0125","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.gastro.2003.06.005","article-title":"Enterohepatic bile salt transporters in normal physiology and liver disease","volume":"126","author":"Kullak-Ublick","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.01.031_b0130","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/00004424-200212000-00007","article-title":"Gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid interaction with clinical drugs in rats","volume":"37","author":"Kato","year":"2002","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/jmri.22458","article-title":"Evaluation of possible drug-drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP)","volume":"33","author":"Huppertz","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jhep.2012.01.031_b0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1148\/radiology.199.1.8633143","article-title":"Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence","volume":"199","author":"Reimer","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2012.01.031_b0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiology.200.1.8657946","article-title":"Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA","volume":"200","author":"Vogl","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2012.01.031_b0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/RLI.0b013e3181caea5b","volume":"45","author":"Ichikawa","year":"2010","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0155","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1148\/radiol.10091388","article-title":"Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma","volume":"255","author":"Ahn","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2012.01.031_b0160","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1148\/radiol.10091334","article-title":"Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis","volume":"256","author":"Di Martino","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2012.01.031_b0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5009\/gnl.2011.5.1.15","article-title":"Current limitations and potential breakthroughs for the early diagnosis of hepatocellular carcinoma","volume":"5","author":"Kim","year":"2010","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhep.2012.01.031_b0170","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s00330-010-1977-2","article-title":"Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and GD-EOB-DTPA-enhanced MR imaging","volume":"21","author":"Lowenthal","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0175","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jmri.21839","article-title":"Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxectic acid","volume":"30","author":"Kim","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jhep.2012.01.031_b0180","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s00330-009-1651-8","article-title":"Imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium","volume":"20","author":"Choi","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0185","doi-asserted-by":"crossref","first-page":"S753","DOI":"10.1007\/s00330-009-1432-4","article-title":"Health-economic evaluation of three imaging strategies in patients with suspected colorectal liver metastases: GD-EOB-DTPA-enhanced MRI vs. extracellular contrast media-enhanced MRI and 3-phase MDCT in Germany, Italy and Sweden","volume":"19","author":"Zech","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0190","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.acra.2011.08.007","article-title":"Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents","volume":"18","author":"Husarik","year":"2011","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0195","doi-asserted-by":"crossref","unstructured":"Gupta RT, Marin D, Boll DT, Husarik DB, Davis DE, Feuerlein S, et al. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium. Eur J Radiol, 2011 [Epub ahead of print].","DOI":"10.1016\/j.ejrad.2011.10.014"},{"key":"10.1016\/j.jhep.2012.01.031_b0200","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.01.031_b0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.21966","article-title":"Diagnosis of hepatic nodules 20mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma","volume":"47","author":"Forner","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.01.031_b0210","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.22709","article-title":"Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia","volume":"49","author":"International Consensus Group for Hepatocellular Neoplasia","year":"2009","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.jhep.2012.01.031_b0215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000315235","article-title":"Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?","volume":"78","author":"Kudo","year":"2010","journal-title":"Oncology"},{"key":"10.1016\/j.jhep.2012.01.031_b0220","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00330-010-1812-9","article-title":"GD-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow","volume":"20","author":"Kogita","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0225","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1148\/radiol.10091885","article-title":"Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging","volume":"256","author":"Motosugi","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2012.01.031_b0230","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.11101840","article-title":"Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging","volume":"261","author":"Sano","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2012.01.031_b0235","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3348\/kjr.2011.12.4.403","article-title":"Consensus report of the 4th international forum for gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging","volume":"12","author":"Lee","year":"2011","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0240","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1148\/radiol.10091557","article-title":"Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging \u2013 correlation with expression of sinusoidal and canalicular transporters and bile accumulation","volume":"255","author":"Tsuboyama","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2012.01.031_b0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mri.2010.07.019","article-title":"Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of GD-EOB-DTPA-enhanced MRI: initial experience","volume":"29","author":"Lee","year":"2011","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.jhep.2012.01.031_b0250","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1478-3231.2005.01033.x","article-title":"Hepatobiliary transporter expression in human hepatocellular carcinoma","volume":"25","author":"Zollner","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2012.01.031_b0255","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1148\/radiol.10092214","article-title":"Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging \u2013 correlation with molecular transporters and histopathologic features","volume":"256","author":"Kitao","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2012.01.031_b0260","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00428-011-1099-5","article-title":"OATP 1B1\/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation","volume":"459","author":"Vasuri","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jhep.2012.01.031_b0265","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1007\/s00330-011-2165-8","article-title":"The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging","volume":"21","author":"Kitao","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0270","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2214\/AJR.10.5439","article-title":"Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics","volume":"197","author":"Choi","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"Suppl. 3","key":"10.1016\/j.jhep.2012.01.031_b0275","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1016\/S1590-8658(10)60511-7","article-title":"Molecular classification of hepatocellular carcinoma","volume":"42","author":"Zucman-Rossi","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2012.01.031_b0280","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1248\/bpb.34.433","article-title":"Multidrug resistance protein 2 implicates anticancer drug-resistance to sorafenib","volume":"34","author":"Shibayama","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jhep.2012.01.031_b0285","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/path.1852","article-title":"Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver","volume":"207","author":"Vander Borght","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.jhep.2012.01.031_b0290","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/RLI.0b013e3181705cd1","article-title":"Diagnostic performance and description of morphological features of focal nodular hyperplasia in GD-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial","volume":"43","author":"Zech","year":"2008","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0295","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2169\/internalmedicine.50.4637","article-title":"Focal nodular hyperplasia-like nodule with reduced expression of organic anion transporter 1B3 in alcoholic liver cirrhosis","volume":"50","author":"Doi","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.jhep.2012.01.031_b0300","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hep.24158","article-title":"Hepatocyte-specific magnetic resonance imaging contrast agents","volume":"53","author":"Fidler","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.01.031_b0435","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00261-011-9721-1","article-title":"Multiple hepatocellular adenomas in a patient with glycogen storage disease type I: various enhancement patterns in MRI with Gd-EOB-DTPA","volume":"37","author":"Sakamoto","year":"2012","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.jhep.2012.01.031_b0310","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1148\/radiol.2342040278","article-title":"Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT \u2013 initial observations","volume":"234","author":"Huppertz","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2012.01.031_b0315","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/hep.24147","article-title":"Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification","volume":"53","author":"Ronot","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.01.031_b0320","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejrad.2010.03.008","article-title":"Hepatobiliary transit times of gadoxetate disodium (Primovist) for protocol optimization of comprehensive MR imaging of the biliary system \u2013 what is normal?","volume":"79","author":"Ringe","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0325","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1148\/rg.296095501","article-title":"Biliary MR imaging with Gd-EOB-DTPA and its clinical applications","volume":"29","author":"Lee","year":"2009","journal-title":"Radiographics"},{"key":"10.1016\/j.jhep.2012.01.031_b0330","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/RCT.0b013e31821f4e29","article-title":"Gd-EOB-DTPA as a functional MR cholangiography contrast agent: imaging gallbladder filling in patients with and without hepatobiliary dysfunction","volume":"35","author":"Smith","year":"2011","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.jhep.2012.01.031_b0335","doi-asserted-by":"crossref","unstructured":"Tamada T, Ito K, Sone T, Kanki A, Sato T, Higashi H. GD-EOB-DTPA-enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers. Eur J Radiol, 2010 [Epub ahead of print].","DOI":"10.1016\/j.ejrad.2010.08.033"},{"key":"10.1016\/j.jhep.2012.01.031_b0340","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00330-008-0929-6","article-title":"Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma","volume":"18","author":"Tschirch","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0345","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1148\/radiol.10091130","article-title":"Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable?","volume":"255","author":"Ringe","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2012.01.031_b0350","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/gut.2010.208595","article-title":"Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis","volume":"59","author":"Zipprich","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2012.01.031_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00534-004-0951-2","article-title":"Assessment of hepatic reserve for the indication of hepatic resection","volume":"12","author":"Belghiti","year":"2005","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.jhep.2012.01.031_b0440","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/MNM.0b013e328347a9ed","article-title":"Toward a total and regional scintigraphic liver function test enabling assessment of future remnant liver function","volume":"32","author":"Bennink","year":"2011","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.jhep.2012.01.031_b0365","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00280-004-0793-2","article-title":"In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein","volume":"54","author":"Hendrikse","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jhep.2012.01.031_b0370","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jhep.2010.07.047","article-title":"Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green","volume":"54","author":"de Graaf","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.01.031_b0375","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3348\/kjr.2004.5.4.231","article-title":"Quantitative evaluation of liver function with MRI using Gd-EOB-DTPA","volume":"5","author":"Ryeom","year":"2004","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0380","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/jmri.21956","article-title":"Liver parenchymal enhancement of hepatocyte-phase images in GD-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?","volume":"30","author":"Motosugi","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jhep.2012.01.031_b0385","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/jmri.21801","article-title":"Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI","volume":"29","author":"Nilsson","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jhep.2012.01.031_b0390","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejrad.2008.09.036","article-title":"New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on GD-EOB-DTPA-enhanced MRI","volume":"73","author":"Tsuda","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jhep.2012.01.031_b0395","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1148\/radiol.10092065","article-title":"Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi \u2013 gadoxetic acid-enhanced MR imaging","volume":"256","author":"Tsuda","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2012.01.031_b0400","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mrm.10045","article-title":"Assessment of hepatic perfusion parameters with dynamic MRI","volume":"47","author":"Materne","year":"2002","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jhep.2012.01.031_b0405","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/mrm.10420","article-title":"Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrast-enhanced MRI in the rabbit","volume":"49","author":"Van Beers","year":"2003","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.jhep.2012.01.031_b0410","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejps.2006.05.007","article-title":"An integrated approach to model hepatic drug clearance","volume":"29","author":"Liu","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jhep.2012.01.031_b0415","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jmri.1880040321","article-title":"Gd-EOB-DTPA enhancement pattern of hepatocellular carcinomas in rats: comparison with Tc-99m-IDA uptake","volume":"4","author":"Van Beers","year":"1994","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jhep.2012.01.031_b0420","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/jpet.110.175406","article-title":"How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liver","volume":"336","author":"Millet","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2012.01.031_b0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.11.048","article-title":"The emerging role of transport systems in liver function tests","volume":"675","author":"Stieger","year":"2012","journal-title":"Eur J Pharmacol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812002486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812002486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T16:13:51Z","timestamp":1742919231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827812002486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0168827812002486"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2012.01.031","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}